Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Urokinase-Type Plasminogen Activator and Gamma-Linolenic Acid

Research Papers that Mention the Interaction

This phenomenon may be explained by the fact that certain EFAs, such as gamma-linolenic acid (GLA) and eicosapentaenoic acid (EPA), inhibit uPA activity.
Prostaglandins, leukotrienes, and essential fatty acids  •  1996  |  View Paper
Oxidation of LA by lipoxidase especially increases tumour cell death, whilst GLA inhibits urokinase-type plasminogen activator (uPA) activity.
Medical hypotheses  •  1994  |  View Paper
Both GLA (n-6) and EPA (n-3) acted as competitive inhibitors of UK with Ki values of 120 and 96 microM respectively.
Prostaglandins, leukotrienes, and essential fatty acids  •  1994  |  View Paper